Benzonatate
- Product NDC
- 71626-201
- 11-digit product format
- 716260201
- Labeler code
- 71626
- Product ID
- 71626-201_d6a5f3b3-799f-41cf-85cf-51a449196ac8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Benzonatate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Medstone Pharma LLC
- Application
- ANDA202765
- Marketing category
- ANDA
- Marketing start
- 2018-10-31
- Marketing end
- 0000-00-00
- Substance
- BENZONATATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71626-201-01 | Benzonatate | 100 in 1 BOTTLE | CAPSULE | 100 | | 2 |
| 71626-201-05 | Benzonatate | 500 in 1 BOTTLE | CAPSULE | 500 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71626-201 | BENZONATATE CAPSULE [MEDSTONE PHARMA LLC] | 2 | Legacy NDC, 2 package rows | 20200401_d58b2044-918c-4626-815f-957530611495.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71626-201-01 | 71626020101 | 100 CAPSULE in 1 BOTTLE (71626-201-01) | 100 capsule | 2018-10-31 | 0000-00-00 | No | No | Current |
| 71626-201-05 | 71626020105 | 500 CAPSULE in 1 BOTTLE (71626-201-05) | 500 capsule | 2018-10-31 | 0000-00-00 | No | No | Current |